- Home
- GLBZ vs TRIB Comparison
GLBZ vs TRIB Comparison
Compare GLBZ & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBZ
- TRIB
- Stock Information
- Founded
- GLBZ 1949
- TRIB 1992
- Country
- GLBZ United States
- TRIB Ireland
- Employees
- GLBZ N/A
- TRIB N/A
- Industry
- GLBZ Major Banks
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GLBZ Finance
- TRIB Health Care
- Exchange
- GLBZ Nasdaq
- TRIB Nasdaq
- Market Cap
- GLBZ 14.1M
- TRIB 13.0M
- IPO Year
- GLBZ N/A
- TRIB N/A
- Fundamental
- Price
- GLBZ $5.01
- TRIB $0.67
- Analyst Decision
- GLBZ
- TRIB
- Analyst Count
- GLBZ 0
- TRIB 0
- Target Price
- GLBZ N/A
- TRIB N/A
- AVG Volume (30 Days)
- GLBZ 10.7K
- TRIB 2.4M
- Earning Date
- GLBZ 07-25-2025
- TRIB 08-13-2025
- Dividend Yield
- GLBZ 2.00%
- TRIB N/A
- EPS Growth
- GLBZ N/A
- TRIB N/A
- EPS
- GLBZ 0.01
- TRIB N/A
- Revenue
- GLBZ $11,536,000.00
- TRIB $61,555,000.00
- Revenue This Year
- GLBZ N/A
- TRIB $13.51
- Revenue Next Year
- GLBZ N/A
- TRIB $13.14
- P/E Ratio
- GLBZ $380.14
- TRIB N/A
- Revenue Growth
- GLBZ N/A
- TRIB 8.31
- 52 Week Low
- GLBZ $3.86
- TRIB $0.48
- 52 Week High
- GLBZ $6.99
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- GLBZ 50.81
- TRIB 48.68
- Support Level
- GLBZ $4.02
- TRIB $0.60
- Resistance Level
- GLBZ $5.25
- TRIB $0.87
- Average True Range (ATR)
- GLBZ 0.29
- TRIB 0.08
- MACD
- GLBZ 0.01
- TRIB 0.01
- Stochastic Oscillator
- GLBZ 68.29
- TRIB 33.94
About GLBZ Glen Burnie Bancorp
Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.